Skip to content

Social Anxiety Telehealth Therapy Study

Social Anxiety Telehealth Therapy Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04450303
Enrollment
26
Registered
2020-06-29
Start date
2020-10-30
Completion date
2021-06-02
Last updated
2021-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social Anxiety

Brief summary

The COVID-19 pandemic has substantially increased the risk of adverse mental health outcomes; while physical distancing is required to reduce infection risk, it also increases loneliness and isolation and prevents access to traditional in-person therapy, which further contribute to risk of adverse mental health outcomes. These problems may be especially acute for individuals with social anxiety disorder (as many as 12% of Americans), however there is a limited evidence-base for telehealth options to directly address social anxiety. This project aims to adapt exposure therapy for social anxiety to a telehealth and physical distancing-compatible intervention, and test whether this effectively decreases loneliness in adults with elevated social anxiety.

Interventions

BEHAVIORALTelehealth CBT

The Coordinated Anxiety Learning and Management (CALM) program is an evidence-based, computer-assisted protocol for cognitive behavioral therapy (CBT) for anxiety, depression, and/or post-traumatic stress. CALM will be implemented via secure and HIPAA compliant video-conferencing software (enterprise Zoom), following modifications to address obstacles associated with physical distancing and the tele-health medium.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18+, * Liebowitz Social Anxiety Scale (LSAS) total score \> 50 * Fluent spoken and written English * Access to the internet via a smartphone or computer with a camera * Ability to provide informed consent.

Exclusion criteria

* History of mania or psychosis * Moderate or severe substance use disorder within the past year * Current psychiatric diagnosis of greater impairment than that arising from social anxiety * High risk for suicide (\>8 on the Mini International Neuropsychiatric Interview suicidality section) * Prior exposure therapy (more than 2 sessions) * Current psychotropic medication use * Current psychotherapy other than couples counseling.

Design outcomes

Primary

MeasureTime frameDescription
Liebowitz Social Anxiety Scale (LSAS)12 weeksSocial anxiety severity, lower scores are better (indicating less anxiety). Minimum score is 0, maximum score is 144.
Satisfaction with Therapy and Therapists Scale (STTS)12 weeksTherapy satisfaction subscale, higher scores are better (indicating greater satisfaction). Minimum score is 6, maximum score is 30.
UCLA Loneliness Scale version 312 weeksLoneliness, lower scores are better (indicating less loneliness). Minimum score is 20, maximum score is 80.

Secondary

MeasureTime frameDescription
Liebowitz Social Anxiety Scale (LSAS)24 weeksSocial anxiety severity, lower scores are better (indicating less anxiety). Minimum score is 0, maximum score is 144.
UCLA Loneliness Scale version 324 weeksLoneliness, lower scores are better (indicating less loneliness). Minimum score is 20, maximum score is 80.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026